0001179110-21-002796.txt : 20210303
0001179110-21-002796.hdr.sgml : 20210303
20210303193952
ACCESSION NUMBER: 0001179110-21-002796
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210301
FILED AS OF DATE: 20210303
DATE AS OF CHANGE: 20210303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOREVIC JASON N
CENTRAL INDEX KEY: 0001208500
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37477
FILM NUMBER: 21711714
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Teladoc Health, Inc.
CENTRAL INDEX KEY: 0001477449
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
IRS NUMBER: 043705970
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
BUSINESS PHONE: 2036352002
MAIL ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
FORMER COMPANY:
FORMER CONFORMED NAME: Teladoc, Inc.
DATE OF NAME CHANGE: 20091123
4
1
edgar.xml
FORM 4 -
X0306
4
2021-03-01
0
0001477449
Teladoc Health, Inc.
TDOC
0001208500
GOREVIC JASON N
C/O TELADOC HEALTH, INC.,
2 MANHATTANVILLE ROAD, SUITE 203
PURCHASE
NY
10577
1
1
0
0
Chief Executive Officer
Common Stock
2021-03-01
4
M
0
13281
A
540469
D
Common Stock
2021-03-01
4
M
0
13944
A
554413
D
Common Stock
2021-03-02
4
S
0
12674
224.282
D
541739
D
Common Stock
2021-03-02
4
M
0
9104
A
550843
D
Common Stock
2021-03-02
4
M
0
15476
A
566319
D
Common Stock
2021-03-02
4
S
0
30000
223.5337
D
536319
D
Restricted Stock Units
2021-03-01
4
M
0
13281
0
D
Common Stock
13281
0
D
Performance Stock Units
2021-03-01
4
M
0
13944
0
D
Common Stock
13944
0
D
Restricted Stock Units
2021-03-02
4
M
0
9104
0
D
Common Stock
9104
18207
D
Performance Stock Units
2021-03-02
4
A
0
46430
0
A
Common Stock
46430
46430
D
Performance Stock Units
2021-03-02
4
M
0
15476
0
D
Common Stock
15476
30954
D
Restricted Stock Units
2021-03-02
4
A
0
22944
0
A
Common Stock
22944
22944
D
Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit and performance stock unit awards.
This transaction was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2020.
Represents the weighted average price of transactions ranging from $216.40 to $231.14. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
On March 1, 2018, the reporting person was granted 39,842 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
On March 4, 2019, the reporting person earned 41,834 performance stock units, vesting in three substantially equal annual installments beginning on March 4, 2019 and March 1 each subsequent year.
On March 2, 2020, the reporting person was granted 27,311 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
The performance stock units vest in three substantially equal annual installments beginning on March 2, 2021.
On March 2, 2021, the reporting person earned 46,430 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021.
Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
The restricted stock units vest in three substantially equal annual installments beginning on the first anniversary of the grant date.
Performance award amount determined based on metrics in respect of the issuer's 2020 financial results.
/s/ Adam C. Vandervoort, attorney-in-fact
2021-03-03